PHIP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.090400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.143400E-01
Normal-vs-Stage2
6.583800E-02
Normal-vs-Stage3
5.802000E-02
Normal-vs-Stage4
5.236000E-01
Stage1-vs-Stage2
2.266600E-01
Stage1-vs-Stage3
1.498180E-01
Stage1-vs-Stage4
9.577600E-01
Stage2-vs-Stage3
1.199030E-01
Stage2-vs-Stage4
3.552000E-01
Stage3-vs-Stage4
5.657800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.908300E-02
Normal-vs-AfricanAmerican
4.923600E-01
Normal-vs-Asian
8.924100E-02
Caucasian-vs-AfricanAmerican
2.462400E-01
Caucasian-vs-Asian
5.116800E-01
AfricanAmerican-vs-Asian
1.660430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.252000E-02
Normal-vs-Female
1.123010E-01
Male-vs-Female
4.939200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.124200E-01
Normal-vs-Age(41-60Yrs)
1.512390E-01
Normal-vs-Age(61-80Yrs)
7.595800E-02
Normal-vs-Age(81-100Yrs)
8.827900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.235800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.089600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.058600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.076430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.795800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.646000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.255800E-02
Normal-vs-Daily Drinker
2.645800E-02
Normal-vs-Weekly Drinker
2.215400E-01
Normal-vs-Occasional Drinker
2.677800E-01
Normal-vs-Social Drinker
2.911600E-01
Non Drinker-vs-Daily Drinker
4.294800E-01
Non Drinker-vs-Weekly Drinker
2.468800E-01
Non Drinker-vs-Occasional Drinker
1.885450E-01
Non Drinker-vs-Social Drinker
3.862400E-01
Daily Drinker-vs-Weekly Drinker
6.925400E-01
Daily Drinker-vs-Occasional Drinker
6.918100E-02
Daily Drinker-vs-Social Drinker
1.819840E-01
Weekly Drinker-vs-Occasional Drinker
3.122000E-02
Weekly Drinker-vs-Social Drinker
1.245170E-01
Occasional Drinker-vs-Social Drinker
8.139200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.266300E-02
Normal-vs-Grade 2
2.882100E-02
Normal-vs-Grade 3
4.541600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.638000E-01
Grade 1-vs-Grade 3
7.620800E-01
Grade 1-vs-Grade 4
5.266300E-02
Grade 2-vs-Grade 3
5.317800E-01
Grade 2-vs-Grade 4
2.882100E-02
Grade 3-vs-Grade 4
4.541600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.057600E-02
Normal-vs-NonDiabetic
4.191900E-02
Diabetic-vs-NonDiabetic
4.226000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.048000E-02
Normal-vs-NoPancreatitis
4.417600E-02
Pancreatitis-vs-NoPancreatitis
2.267000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.719640E-01
Normal-vs-N1
6.442500E-02
N0-vs-N1
5.986400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.139550E-01
Normal-vs-TP53-NonMutant
4.107400E-01
TP53-Mutant-vs-TP53-NonMutant
1.169560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
